Vera Therapeutics CEO Marshall Fordyce's 2022 pay jumps 176% to $4.1M
Vera Therapeutics reports 2022 executive compensation
By ExecPay News
Published: March 30, 2023
Vera Therapeutics reported fiscal year 2022 executive compensation information on March 30, 2023.
In 2022, three executives at Vera Therapeutics received on average a compensation package of $2.7M, a 63% increase compared to previous year.
Average pay of disclosed executives at Vera Therapeutics
Marshall Fordyce, Chief Executive Officer, received $4.1M in total, which increased by 176% compared to 2021. 60% of Fordyce's compensation, or $2.5M, was in option awards. Fordyce also received $278K in non-equity incentive plan, $551K in salary, as well as $814K in stock awards.
Sean Grant, Chief Financial Officer, received a compensation package of $2.5M, which increased by 19% compared to previous year. 51% of the compensation package, or $1.3M, was in option awards.
Celia Lin, Chief Medical Officer, earned $1.6M in 2022, a 10% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 30, 2023.